GO
Loading...

DS Healthcare Group to Enter $24 Billion China Beauty and Personal Care Market

Pompano Beach, Sept. 30, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ:DSKX), a leading developer of personal care products, today announced it has signed an agreement with a distributor in China and will soon launch its products into the fast-growing Chinese beauty and personal care market. The Company expects to begin generating revenues from sales in China in the fourth quarter of this year.

According to Euromonitor International, total sales of beauty and personal care products in China tripled in size from 2000 to reach an estimated $24 billion in 2010. Euromonitor projects the market will grow to $34 billion by 2015. Analysts believe this rapid pace is driven by China's fast growing middle class.

"We believe international expansion will be a key driver for our revenue growth in the future. Our products have universal appeal and we are ready to meet demand in an increasing number of markets. Having started to gain traction in Brazil, we are now ready to enter China," stated DS Healthcare President and CEO Daniel Khesin.

DS Healthcare currently distributes its products in over 15 countries throughout Europe, Asia, the Middle East, and South America.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development and distribution of topical therapies for personal care, including what management believes is the world's most effective topical treatment for hair loss. Its products are sold through a network of salons, pharmacies, online retailers, specialty retailers and select department stores. Its brands include DS Laboratories(www.DSLaboratories.com), Sigma Skin (www.(www.SigmaSkin.com), Polaris Research Laboratories (www.PolarisResearchLabs.com) The Pure Guild (www.ThePureGuild.com) and Nutra Origin (www.NutraOrigin.com)

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.

CONTACT: Contact: Laurel Moody Corporate Profile 1.646.810.0608

Source:DS Healthcare Group,Inc.